Another point associated with deals in China.
This current deal seems to be focused entirely on Fokangren and Evolis products alone.
http://www.cellmid.com.au/SiteMedia/W3SVC921/Uploads/Documents/2017 08 01 Chinese Import Permits Received FINAL.pdf
This occurred last year with the Lexilis and Joju products and shipments resumed.
Resumed to whom?
Huana Likang would be my bet.
And didn't the CEO recently say that China sales were improving?
Given the time it took for CDY to get the permits renewed for Lexilis, CDY have taken a different approach by getting the Chinese Company to obtain the permits from the inside, so to speak, which they claim as one of their leading benefits. As the Lexilis permits run out in 2021 perhaps CDY ought to get cracking on the next lot or perhaps get Huana Likang to do a bit of spadework to assist.
The way I see it is we have two lots of product in a pincer movement.
Evolis is to attack the upmarket end of things and pharmacies while Lexilis plugs away with established deals and a possible QVC deal with online shopping.
"And never the twain shall meet"
Nice.
